Potassium iodide and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium iodide (potassium iodide) and Cyclophosphamide (cyclophosphamide). Common drug interactions include depression among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium iodide and Cyclophosphamide. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium iodide?

Potassium iodide has active ingredients of potassium iodide. It is often used in thyroid diseases. eHealthMe is studying from 1,919 Potassium iodide users. Check the latest studies of Potassium iodide.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.



On Aug, 01, 2026

38 people who take Potassium iodide and Cyclophosphamide together, and have interactions are studied.

Potassium iodide and Cyclophosphamide drug interactions.

What are the common drug interactions of Potassium Iodide and Cyclophosphamide, by gender? *:

female:

  1. Depression
  2. Drug ineffective
  3. Hip fracture
  4. Insomnia (sleeplessness)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Spinal fracture (fracture in one of vertebrae)
  7. Weight increased
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Subileus
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. General physical health deterioration (weak health status)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Abdominal hernia
  5. Clostridial infection (infectious conditions by clostridium bacteria)
  6. Depression
  7. Facial pain
  8. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  9. Oedema peripheral (superficial swelling)
  10. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the common drug interactions of Potassium Iodide and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Clostridial infection (infectious conditions by clostridium bacteria)
  3. Facial pain
  4. Stomatitis (inflammation of mucous membrane of mouth)
  5. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  6. Diarrhoea
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Vomiting

10-19:

  1. Alanine aminotransferase increased
  2. Anaemia (lack of blood)
  3. Aspartate aminotransferase increased
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Lymphocyte count decreased
  6. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  7. Platelet count decreased
  8. Small intestinal obstruction (blockage in small intestine)
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. White blood cell count decreased

20-29:

n/a

30-39:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Acute respiratory distress syndrome
  3. Dyspnoea (difficult or laboured respiration)
  4. Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
  5. Immunodeficiency
  6. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  7. Platelet count decreased
  8. Pneumonia
  9. Sepsis (a severe blood infection that can lead to organ failure and death)

40-49:

n/a

50-59:

  1. Depression
  2. Drug ineffective
  3. Hip fracture
  4. Insomnia (sleeplessness)
  5. Spinal fracture (fracture in one of vertebrae)
  6. Weight increased
  7. Subileus
  8. Pulmonary embolism (blockage of the main artery of the lung)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. General physical health deterioration (weak health status)
  3. Platelet count decreased
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Pyrexia (fever)
  6. Abdominal hernia
  7. Depression
  8. Diarrhoea
  9. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  10. Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

  1. Pain: 7 people, 18.42%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 13.16%
  3. T-Cell Lymphoma (a blood cell cancer): 4 people, 10.53%
  4. Neuroblastoma (a cancer that forms in your nerve tissue): 3 people, 7.89%
  5. Blood Pressure Abnormal: 3 people, 7.89%
  6. Acute Febrile Neutrophilic Dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender): 3 people, 7.89%
  7. Recurrent Cancer (repeated cancer): 2 people, 5.26%
  8. Polyarteritis Nodosa (progressive disease of connective tissue): 2 people, 5.26%
  9. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 5.26%
  10. High Blood Pressure: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium iodide and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium iodide and Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium iodide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium iodide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclophosphamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on potassium iodide and cyclophosphamide (the active ingredients of Potassium iodide and Cyclophosphamide, respectively), and Potassium iodide and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: